However, some individuals may experience persistent symptoms throughout treatment
To view a copy of this licence, visit About this article Cite this article Peri, R.V., Anchan, H., Jonnalagadda, K
In 2021, Comirnaty's sales reached $40.4 billion, securing the top position, and in 2022, it maintained its leading position with annual sales of $37.81 billion
Moreover, GLP-1 triggers a change in conformation of its receptor, leading to the activation of a Gs protein and the production of secondary messengers
By distribution channel, the hospital pharmacies segment dominated the market in 2024
Soleiman applies decades of clinical decision-making to laboratory interpretation, side-effect management, and riskbenefit counseling for GLP1based therapies